iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Kronox Lab Sciences IPO to open on 3rd June

30 May 2024 , 08:07 PM

Kronox Lab Sciences’s initial public offering (IPO) will open on June 3rd.  The price band for the IPO has been set at ₹129-136 per share. This IPO will be the 32nd  one for 2024..

The IPO will consist exclusively of an offer-for-sale (OFS) of 95.7 lakh equity shares, with no fresh issue component. Consequently, the proceeds from the issue will go directly to the selling shareholders. Promoters Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani will each be offloading 31.9 lakh shares as part of the OFS.

The public issue is scheduled to close on June 5, with the anchor book opening for a single day on May 31. The company will finalize the basis of allotment by June 6, and successful investors will have shares credited to their demat accounts by June 7. Trading of Kronox Lab shares on the bourses is expected to commence on June 10.

Based in Gujarat, Kronox Lab Sciences specializes in the manufacture of high-purity specialty fine chemicals. These chemicals serve a wide array of industries, including pharmaceuticals, agrochemicals, personal care, metal refineries, and animal health products. The company’s portfolio boasts over 185 products, such as phosphate, sulfate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, and gluconate. These products are supplied to customers in India and over 20 countries worldwide.

Kronox Lab competes with industry players like Tatva Chintan Pharma Chem, Tanfac Industries, Neogen Chemicals, Sigachi Industries, and DMCC Specialty Chemical. The company has demonstrated robust financial performance in recent years. In the financial year ending March 2023, Kronox Lab’s profit grew by 21.9% year-on-year to ₹16.6 Crore, while revenue from operations increased by 16.2% to ₹95.6 Crore. Additionally, the company’s EBITDA (earnings before interest, tax, depreciation, and amortization) for FY23 rose by 11.7% to ₹22 Crore, although the EBITDA margin declined by 90 basis points to 23% compared to FY22.

Pantomath Capital Advisors is serving as the sole book-running lead manager for the IPO, with KFin Technologies acting as the registrar for the offer.

For feedback and suggestions, write to us at editorial@iifl.com

For opening a demat account click on: https://www.indiainfoline.com/

For doing stock trading & investments, go to: https://ttweb.indiainfoline.com/trade/Login.aspx

For loans, go to: https://www.iifl.com/

 

Related Tags

  • Kronox Lab Sciences IPO
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Indian markets close on a positive note
14 Jun 2024|06:41 PM
Sensex and Nifty Surge
14 Jun 2024|06:43 PM
LIC stock price up by more than 5% today
14 Jun 2024|06:44 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.